About American Gene Technologies

americangene.com

American Gene Technologies (AGT) is a gene and cell therapeutics company.

Revenue : 1M-10M Industry : Biotechnology Location : United States Employees : 10-50

SaaS Adoption

SaaS Adoption indicates the level of adoption by this company of software as a service services.

Cloud Adoption

Cloud Adoption indicates the level of adoption by this company of cloud services.

IT Footprint

IT Footprint gives a relative indication of how much IT services this company consumes.

IT Spend

IT Spend shows roughly how much this client spends on IT per year in USD.

Enlyft tracks the use of over 15,000 technologies and has proprietary data on over 18 million companies worldwide.

Know the products your prospects use

Enlyft provides you with access to our real-time data platform where you can access insights into a company’s tech stack, firmographic data, and more.

Vendor Usage

American Gene Technologies uses 5 different technologies from 27 different vendors. They have above average use of several technologies including WooCommerce, React and Microsoft Azure.

Product Categories

American Gene Technologies uses products from 24 different product categories. They are particularly heavy users of products in Web Analytics, Online Advertising, and Web Hosting Services.

Recently Detected Technologies

Enlyft tracks the use of over 15,000 technologies and has proprietary data on over 18 million companies worldwide.

Technology Category Vendor Usage
WooCommerce eCommerce Automattic
React Software Frameworks Facebook Inc
Microsoft Azure Cloud Platforms & Services Microsoft Corporation
Microsoft Azure Active Directory Identity & Access Management Microsoft Corporation
MasterControl Enterprise GRC MasterControl

Are you interested in knowing other companies with similar tech stacks?

Reveal what vendors your prospects are using

Enlyft Sales Insights gives you instant access to the tech stack and firmographics of millions of companies worldwide.
Logos provided by Clearbit

© Enlyft | All rights reserved.